Introduction:
Pharma stock reported a recent Income Tax Department search at its offices and facilities under the Income Tax Act, 1961. The company ensured full cooperation, maintaining transparency and adherence to strong corporate governance practices, with business operations continuing as usual despite minor disruptions.
Share Price movement of Akums Drugs and Pharmaceuticals:
On January 22, 2025, Akums Drugs and Pharmaceuticals Ltd opened at ₹621.15. By 12:00 PM, it traded at ₹596.50, down 5%. The stock reached a high of ₹627.90 and a low of ₹585.20, with a market cap of ₹613.72 crore.
Also Read: Emergency Funds – Why Every Woman Needs One and How to Start!
Akums Drugs and Pharmaceuticals share price fall:
Akums Drugs and Pharmaceuticals Limited informed about a recent search conducted by the Income Tax Department at its offices and manufacturing units under the Income Tax Act, 1961. The company fully cooperated with officials and provided all required clarifications and details.
The company emphasized its commitment to legal compliance and strong corporate governance practices, ensuring transparency throughout the process. Akums assured its continued cooperation with authorities and readiness to provide any additional information if required.
Despite minor operational disruptions during the search, Akums confirmed that business activities continue as usual. The company will adhere to legal disclosure obligations and provide necessary updates, reinforcing its commitment to maintaining trust and operational stability.
Also Read: Best Sectors To Watch For Budget 2025
Recent news About Akums Drugs and Pharmaceuticals :
On December 24, 2024, Akums Drugs announced an agreement with a leading global pharma company to manufacture and supply oral liquid formulations for the European market. The news drove a 5% increase in the company’s share price.
Stock performance of Akums Drugs and Pharmaceuticals for Period of 1 week:
The stock performance of Akums Drugs and Pharmaceuticals showed a modest gain of 0.86% over the past week, reflecting steady investor interest and stable market activity. This performance indicates consistent demand and confidence in the company’s growth potential within its sector.
Also Read: Stocks To Watch For Budget 2025
Shareholding pattern of Akums Drugs and Pharmaceuticals:
| Summary | Dec-24 | Sep-24 |
| Promoter | 75.30% | 75.30% |
| FII | 6.40% | 7.30% |
| DII | 7.00% | 7.50% |
| Public | 8.60% | 7.10% |
| Others | 2.80% | 2.70% |
About Akums Drugs and Pharmaceuticals:
Akums Drugs and Pharmaceuticals is a leading contract manufacturing company in India, specializing in the production of pharmaceutical formulations, nutraceuticals, and herbal products. It offers end-to-end solutions, including research, development, and manufacturing, serving diverse clients across the healthcare sector.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
